ライフサイエンスコーパス: X-ray absorptiometry

1 s, BMC, and body composition via dual-energy x-ray absorptiometry.

2 wer body fat (LBF) was imaged by dual-energy x-ray absorptiometry.

3 nd fat-free mass and fat mass by dual-energy X-ray absorptiometry.

4 y composition was measured using dual-energy x-ray absorptiometry.

5 bar spine (LS), as determined by dual-energy X-ray absorptiometry.

6 ercentage fat (TBPF) measured by dual-energy X-ray absorptiometry.

7 quality that is not provided by dual-energy x-ray absorptiometry.

8 omposition was assessed by using dual-energy X-ray absorptiometry.

9 All subjects underwent standard dual-energy x-ray absorptiometry.

10 nd osteoporosis, measured by the dual-energy X-ray absorptiometry.

11 mass from baseline, assessed by dual-energy x-ray absorptiometry.

12 omposition was measured by using dual-energy X-ray absorptiometry.

13 he lumbar spine and total hip by dual-energy X-ray absorptiometry.

14 density was determined by using dual-energy x-ray absorptiometry.

15 ne (L2-L4) was measured by using dual-energy X-ray absorptiometry.

16 ntage body fat (%BF) measured by dual energy X-ray absorptiometry.

17 MI) and fat-free mass index with dual-energy X-ray absorptiometry.

18 (MPB), and muscle mass by using dual-energy X-ray absorptiometry.

19 nsity measurements obtained from dual-energy x-ray absorptiometry.

20 al density (BMD) was assessed by dual-energy x-ray absorptiometry.

21 mass and waist circumference on dual-energy x-ray absorptiometry.

22 neral density, was determined by dual-energy X-ray absorptiometry.

23 sured by a whole-body scan using dual-energy X-ray absorptiometry.

24 y fat percentage was measured by dual-energy X-ray absorptiometry.

25 -body BMD were measured by using dual-energy X-ray absorptiometry.

26 femoral neck and/or lumbar spine) using dual x-ray absorptiometry.

27 free mass (FFM) were measured by dual-energy X-ray absorptiometry.

28 BMD was measured by using dual-energy X-ray absorptiometry.

29 y Eating Index (HEI) values, and dual-energy X-ray absorptiometry.

30 F and FFM were measured by using dual-energy X-ray absorptiometry.

31 and body composition was quantified by dual x-ray absorptiometry.

32 omposition was measured by using dual-energy X-ray absorptiometry.

33 nd lean mass were measured using dual-energy-x-ray absorptiometry.

34 radius, and hip were measured by dual-energy X-ray absorptiometry.

35 nd spine BMCs were measured with dual-energy X-ray absorptiometry.

36 over 3 y were measured by using dual-energy X-ray absorptiometry.

37 sured at age 9 y with the use of dual-energy X-ray absorptiometry.

38 total hip and lumbar spine using dual-energy x-ray absorptiometry.

39 mic bone density was measured by dual-energy x-ray absorptiometry.

40 as measured at baseline and annually by dual x-ray absorptiometry.

41 index (FFMI) were measured with dual-energy X-ray absorptiometry.

42 ect calorimetry and body composition by dual x-ray absorptiometry.

43 Fat mass was assessed with dual-energy X-ray absorptiometry.

44 with BMD of the lumbar spine and hip at dual x-ray absorptiometry.

45 was assessed by using total-body dual-energy X-ray absorptiometry.

46 feeding with fatness measured by dual-energy X-ray absorptiometry.

47 nd body fat and fat-free mass by dual-energy X-ray absorptiometry.

48 t and lean mass were assessed by dual-energy X-ray absorptiometry.

49 FST) mass were measured by using dual-energy X-ray absorptiometry.

50 y) were measured with the use of dual-energy X-ray absorptiometry.

51 lean mass were measured by using dual-energy X-ray absorptiometry.

52 osition changes were measured by dual-energy X-ray absorptiometry.

53 ssessed at birth with the use of dual-energy X-ray absorptiometry.

54 ensity, typically assessed using dual-energy X-ray absorptiometry.

55 d assays and body composition by dual-energy X-ray absorptiometry.

56 asurement of tHcy and whole-body dual-energy X-ray absorptiometry.

57 fat, lean mass) were measured by dual-energy X-ray absorptiometry.

58 ody composition were assessed by dual-energy X-ray absorptiometry.

59 fspring was assessed at birth by dual-energy X-ray absorptiometry.

60 of the child were assessed with dual-energy X-ray absorptiometry.

61 women at 3 WHI clinics by using dual-energy X-ray absorptiometry.

62 BMD by dual-energy x-ray absorptiometry, 25-hydroxyvitamin D levels, and ot

63 (FFM), and appendicular mass by dual-energy X-ray absorptiometry; activity-related energy expenditur

64 Body composition (dual-energy X-ray absorptiometry), ad libitum energy intake (EI; buf

65 Body composition was measured by dual-energy X-ray absorptiometry and abdominal computed tomographic

66 Dual-energy X-ray absorptiometry and abdominal computed tomography w

67 Dual-energy x-ray absorptiometry and anthropometric data were used t

68 7 years, and body composition by dual-energy X-ray absorptiometry and BP at 9 years, were analysed (n

69 osition and abdominal adiposity (dual energy X-ray absorptiometry and computed tomography scan, respe

70 asses were assessed by combining dual-energy X-ray absorptiometry and computed tomography scanning.

71 ges relate to regional fat gain (dual energy X-ray absorptiometry and computed tomography) and baseli

72 y composition (measured by using dual-energy X-ray absorptiometry and computed tomography), insulin s

73 Body fat was measured with dual energy X-ray absorptiometry and computed tomography.

74 ubjects with fat measurements by dual-energy x-ray absorptiometry and computed tomography.

75 at distribution were measured by dual-energy x-ray absorptiometry and computed tomography.

76 s assessed with a combination of dual-energy X-ray absorptiometry and computed tomography.

77 ne and at the endpoint by use of dual-energy X-ray absorptiometry and computed tomography.

78 Lean mass was estimated by dual X-ray absorptiometry and examined as leg lean mass (LLM)

79 Total percentage fat measured by dual-energy X-ray absorptiometry and fasting serum leptin concentrat

80 nce tests, and total body fat by dual-energy X-ray absorptiometry and intra-abdominal and subcutaneou

81 and fractures have lower aBMD by dual-energy x-ray absorptiometry and lower vBMD, thinner cortices, a

82 we measured body composition by dual energy x-ray absorptiometry and magnetic resonance imaging (MRI

83 were fat mass, fat distribution (dual-energy X-ray absorptiometry and magnetic resonance imaging), an

84 and 2) body fat distribution by dual energy x-ray absorptiometry and magnetic resonance imaging.

85 gynoid fat ratio with the use of dual-energy X-ray absorptiometry and measured the preperitoneal abdo

86 e quality was analyzed using peripheral dual x-ray absorptiometry and micro-computed tomography.

87 the Dallas Heart Study underwent dual energy x-ray absorptiometry and MRI assessment of fat distribut

88 Percent body fat (BF) was assessed via dual X-ray absorptiometry and PA was determined via a multi-s

89 tion was evaluated by means of dual-emission x-ray absorptiometry and skinfold thickness.

90 (13-46% body fat, by whole-body dual-energy X-ray absorptiometry) and insulin action (glucose dispos

91 after bed rest, lean body mass (dual-energy X-ray absorptiometry) and quadriceps cross-sectional are

92 cardiography), body composition (dual-energy x-ray absorptiometry), and blood parameters.

93 raction force, body composition (dual-energy X-ray absorptiometry), and muscle cross-sectional area (

94 m(2) per min), body composition (dual-energy X-ray absorptiometry), and relevant hormonal/metabolic b

95 assessment (echocardiography and dual-energy x-ray absorptiometry); and histology and molecular evalu

96 hip, forearm, and whole body by dual-energy x-ray absorptiometry, and a complete oral health examina

97 by using the 4-component model, dual-energy X-ray absorptiometry, and anthropometry in 234 healthy U

98 e hip, spine, and whole-body, by dual-energy x-ray absorptiometry, and at the heel by ultrasound.

99 ravenous-glucose-tolerance test, dual-energy X-ray absorptiometry, and computed tomography, respectiv

100 ty (aBMD) were assessed by using dual-energy X-ray absorptiometry, and fasting blood was collected fo

101 dy composition was quantified by dual-energy x-ray absorptiometry, and insulin resistance was assesse

102 Body composition was measured by dual-energy X-ray absorptiometry, and insulin sensitivity was measur

103 age body fat was determined with dual-energy X-ray absorptiometry, and intraabdominal adipose tissue

104 rmed using indirect calorimetry, dual energy x-ray absorptiometry, and magnetic resonance imaging sca

105 ity and content were measured by dual-energy X-ray absorptiometry, and markers of bone turnover were

106 tic resonance (MR) spectroscopy, dual-energy x-ray absorptiometry, and multislice abdominal MR imagin

107 score, total fat mass index from dual-energy x-ray absorptiometry, and overweight or obesity, defined

108 beled water, body composition by dual-energy X-ray absorptiometry, and physical activity by accelerom

109 ndroid:gynoid fat ratio by using dual-energy X-ray absorptiometry, and preperitoneal abdominal fat by

110 body composition with the use of dual-energy X-ray absorptiometry, and questionnaire-derived percepti

111 -hour urine calcium measurement, dual-energy x-ray absorptiometry, and supplementation for vitamin D

112 t mass by physical examinations, dual-energy x-ray absorptiometry, and ultrasound, respectively.

113 ion [VO2]), percent body fat via dual-energy x-ray absorptiometry, and visceral fat via magnetic reso

114 Body Composition Study underwent dual-energy X-ray absorptiometry annually from 1997 to 2003.

115 d fat mass (FM) were assessed by dual-energy X-ray absorptiometry annually over a mean (+/-SD) of 4.9

116 mic clamp), body composition (by dual-energy X-ray absorptiometry), as well as hepatic fat content an

117 Dual x-ray absorptiometry-assessed body composition (includin

118 en were aged 4 and 6 y were BMI, dual-energy X-ray absorptiometry-assessed fat mass, overweight, or o

119 irth and at 4 and 6 y of age for dual-energy X-ray absorptiometry assessment of lean and fat mass.

120 In a subgroup (n = 766), dual-energy X-ray absorptiometry assessment of total abdominal fat w

121 GTT), body composition analysis (dual-energy X-ray absorptiometry), assessment of glucocorticoid meta

122 al neck) were evaluated by using dual-energy X-ray absorptiometry at 5 and 20 wk postpartum.

123 02494) who had been scanned with dual-energy X-ray absorptiometry at 52 wk of lactation (L52; n = 79)

124 onatal body composition was assessed by dual X-ray absorptiometry at age 2 weeks.

125 and the offspring had undergone dual-energy x-ray absorptiometry at age 9-10 years.

126 bone mineral density was measured with dual x-ray absorptiometry at baseline and again an average of

127 ty (SBMD) were assessed by using dual-energy X-ray absorptiometry at baseline and at 2 annual follow-

128 ght x 100, was measured by using dual-energy X-ray absorptiometry at baseline and at 3 y.

129 LBM was measured by total-body dual-energy x-ray absorptiometry at study baseline and at 12, 24, an

130 GV) was measured with the use of dual-energy X-ray absorptiometry at Tanner stage 4.

131 sing anthropometric measures and dual-energy X-ray absorptiometry at the baseline visit.

132 Patients underwent dual x-ray absorptiometry at the hip and spine and hand radio

133 , and bone area were assessed by dual-energy X-ray absorptiometry at the median age of 6 y.

134 od total body bone mass by using dual-energy X-ray absorptiometry at the median age of 6.0 y.

135 ntent (BMC) Z-scores measured by dual energy X-ray absorptiometry at the one-third distal radius, in

136 l bone mineral density (aBMD) by dual-energy x-ray absorptiometry at the spine, hip, and radius, and

137 ge from baseline in areal BMD by dual-energy x-ray absorptiometry at the total hip through month 12 (

138 ediction than that achieved with dual-energy x-ray absorptiometry-based BMD.

139 e relation of anthropometric and dual-energy X-ray absorptiometry-based measures of adiposity with IS

140 Body composition was measured by dual-energy x-ray absorptiometry biweekly, resting energy expenditur

141 ineral density (BMD) measured by dual-energy X-ray absorptiometry, blood samples, diet, physical acti

142 body composition with the use of dual-energy X-ray absorptiometry, blood volume with the use of a car

143 as evaluated in association with dual-energy x-ray absorptiometry body composition measures among 15,

144 Using yearly dual-energy x-ray absorptiometry, body composition was assessed in t

145 ne mineral content obtained from dual-energy X-ray absorptiometry, body density from underwater weigh

146 d thicknesses, and waist girth), dual-energy X-ray absorptiometry, body density, bioelectrical impeda

147 l density (aBMD) measurements by dual-energy x-ray absorptiometry cannot assess bone microstructural

148 echniques such as anal cytology, dual energy x-ray absorptiometry, carotid ultrasonography, echocardi

149 composition (skinfold thickness, dual-energy X-ray absorptiometry), comprehensive echocardiography, a

150 organ fat, and adipocyte size by dual-energy X-ray absorptiometry, CT scan, and adipose tissue biopsy

151 Mouse Genome Project focusing on Dual-Energy X-Ray Absorptiometry data for the analysis of mouse knoc

152 Whole-body dual-energy X-ray absorptiometry data obtained from the 1999-2004 NH

153 on the basis of NHANES 1999-2004 dual-energy X-ray absorptiometry data, provide a reference in the US

154 Measures of dual-energy X-ray absorptiometry-derived fat mass included the limb-

155 thwest England aged 21-60 y with dual-energy X-ray absorptiometry-derived fat mass indexes </=11 kg/m

156 h West England aged 21-60 y with dual-energy X-ray absorptiometry-derived fat mass indexes of >/=13 k

157 beneficiaries with HIV underwent dual energy x-ray absorptiometry (DEXA) screening in 2001-2.

158 Dual X-ray absorptiometry (DEXA) was used to determine bone m

159 5s evaluated fat distribution by dual-energy X-ray absorptiometry (DEXA).

160 ks, mice underwent live imaging (dual energy x-ray absorptiometry [DEXA] scanning, two-dimensional ec

161 Lumbar spine dual X-ray absorptiometry does not consistently distinguish c

162 hese measures compare with FM by dual-energy X-ray absorptiometry (DXA) 2 wk postpartum.

163 with measures obtained by using dual-energy X-ray absorptiometry (DXA) and anthropometric measures.

164 sure total body protein by using dual-energy X-ray absorptiometry (DXA) and bioimpedance analysis (BI

165 pared adipose tissue measured by dual-energy X-ray absorptiometry (DXA) and magnetic resonance imagin

166 ge for subsequent development of dual-energy x-ray absorptiometry (DXA) and quantitative computed tom

167 uits, and bone mineral density (BMD) by Dual X-Ray Absorptiometry (DXA) and repeated after 12 weeks o

168 x (BMI), waist circumference and Dual-energy X-ray absorptiometry (DXA) assessed fat mass), and logis

169 TBV measure with the use of only dual-energy X-ray absorptiometry (DXA) attenuation values for use in

170 dy cohort members with age 15 yr dual-energy x-ray absorptiometry (DXA) bone outcomes (whole body, lu

171 20 years old in 1976 underwent a dual-energy X-ray absorptiometry (DXA) bone scan.

172 Dual energy X-ray absorptiometry (DXA) can be used to determine abdo

173 Dual-energy x-ray absorptiometry (DXA) can provide accurate measurem

174 g magnetic resonance imaging and dual-energy X-ray absorptiometry (DXA) estimates of evaluated compon

175 1 and 5 (mean 8.3 years apart) and hip dual x-ray absorptiometry (DXA) had been performed (2 years a

176 en biomechanical CT analysis and dual-energy x-ray absorptiometry (DXA) in 136 women (age range, 43-9

177 equences for the clinical use of dual-energy X-ray absorptiometry (DXA) in the diagnosis and treatmen

178 ography (CT) in combination with dual-energy x-ray absorptiometry (DXA) is cost-effective as a screen

179 ow bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA) is the primary way to identif

180 an, 7.7 years) using anthropometric and dual X-ray absorptiometry (DXA) measurements.

181 Recently, dual-energy X-ray absorptiometry (DXA) modeling of organ-tissue mass

182 jective food intake measures and dual-energy X-ray absorptiometry (DXA) scan for body composition wil

183 t (A(1)R-knockout) mice was analyzed by dual x-ray absorptiometry (DXA) scanning, and the trabecular

184 water (DLW) along with multiple dual-energy X-ray absorptiometry (DXA) scans to measure changes in b

185 Dual-energy x-ray absorptiometry (DXA) scans were performed before s

186 density at week 48, assessed by dual energy x-ray absorptiometry (DXA) scans.

187 Dual-energy X-ray absorptiometry (DXA) was used for an assessment of

188 h abdominal multidetector CT and dual-energy x-ray absorptiometry (DXA) within 6 months of each other

189 essed within 2 weeks of birth by dual-energy x-ray absorptiometry (DXA), analysed in all randomly ass

190 s, bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA), and BMD by quantitative comp

191 g adults aged 8 to 20 years with dual-energy x-ray absorptiometry (DXA), anthropometric, demographic,

192 Participants had dual-energy x-ray absorptiometry (DXA), entered a clinical BMD regis

193 competence, and remodeling with dual energy x-ray absorptiometry (DXA), high-resolution peripheral q

194 Assessment Tool (FRAX), without dual-energy X-ray absorptiometry (DXA), in all HIV-infected men aged

195 fect of Pb on bone quality using dual-energy X-ray absorptiometry (DXA), micro-computed tomography, R

196 of body composition, measured by dual-energy x-ray absorptiometry (DXA), to increased serum alanine a

197 an alternate measure of obesity, dual-energy X-ray absorptiometry (DXA)-derived visceral-fat-volume m

198 ody composition were measured by dual-energy X-ray absorptiometry (DXA).

199 e areal BMD were determined with dual-energy x-ray absorptiometry (DXA).

200 e (L2-L4) were measured by using dual-energy X-ray absorptiometry (DXA).

201 d at age 20 y through the use of dual-energy X-ray absorptiometry (DXA).

202 and body composition was measured using dual x-ray absorptiometry (DXA).

203 A) levels; (3) total body fat by dual energy x-ray absorptiometry (DXA); (4) liver and muscle insulin

204 ody energy stores [measured with dual-energy X-ray absorptiometry (DXA)] and energy expenditure [meas

205 cy on offspring fatness (BMI and dual-energy X-ray absorptiometry [DXA] determined fat mass index [FM

206 Bone densities (dual x-ray absorptiometry [DXA]) were normal, low, or osteopo

207 ee imaging methods (radiography, dual-energy x-ray absorptiometry [DXA], and quantitative computed to

208 ed of alternative tests (central dual-energy x-ray absorptiometry [DXA], calcaneal quantitative ultra

209 Leg lean mass (via dual-energy X-ray absorptiometry; DXA) and strength were determined.

210 han or equal to 2 posttransplant dual energy X-ray absorptiometry examinations.

211 calorimetry), body composition (dual-energy X-ray absorptiometry), fasting appetite ratings (visual

212 alyses of dynamic knee loads as well as dual x-ray absorptiometry for determination of bone mineral d

213 t mass and bone mass measured by dual-energy X-ray absorptiometry for each study year.

214 nts with RA underwent total body dual-energy x-ray absorptiometry for measurement of total and region

215 atched non-RA controls underwent dual-energy x-ray absorptiometry for measurement of total and region

216 ecommends that clinicians obtain dual-energy x-ray absorptiometry for men who are at increased risk f

217 ody-composition data measured by dual-energy X-ray absorptiometry from NHANES.

218 muscle mass were measured using dual energy x-ray absorptiometry; grip strength and information on l

219 e parameters were analyzed using dual energy x-ray absorptiometry, histomorphometry, and vertebral co

220 is, mean (SD) whole-body BMD z score by dual x-ray absorptiometry improved by 0.25 (0.78) in the inte

221 d skeletal muscle mass using whole-body dual X-ray absorptiometry in 142 adult lung transplant candid

222 ged 8-19 y was measured by using dual-energy X-ray absorptiometry in 1999-2004 as part of a health ex

223 BMD (in g/cm(2)) was measured by dual-energy X-ray absorptiometry in 2544 men and women (mean age: 58

224 omposition was measured by using dual-energy X-ray absorptiometry in 294 adult women at risk of weigh

225 omposition was measured by using dual-energy X-ray absorptiometry in 50 female, adult patients with A

226 dy LM and FM were assessed using dual-energy x-ray absorptiometry in 78 CD subjects at diagnosis, 6,

227 ith body composition measured by dual-energy X-ray absorptiometry in 984 Hispanic children and adoles

228 body composition as measured by dual-energy X-ray absorptiometry in a large sample of twins from the

229 BF% was measured by dual-energy x-ray absorptiometry in a population-based cross-section

230 f hip and spine were detected by dual-energy x-ray absorptiometry in both groups.

231 place) and adiposity measured by dual-energy X-ray absorptiometry in US children.

232 percentage body fat (measured by dual-energy X-ray absorptiometry) in adults in a large nationally re

233 dy mass and whole-body fat mass (dual-energy X-ray absorptiometry) increased over 12 weeks in Control

234 Body weight was measured, and dual-energy X-ray absorptiometry, indirect calorimetry (men only), a

235 ith lower radiation emissions by dual-energy X-ray absorptiometry instruments now permit the safe mea

236 rd assessments of body composition (via dual X-ray absorptiometry), insulin sensitivity (via hyperins

237 Dual x-ray absorptiometry is currently the state-of-the-art t

238 fractures, but correlation with dual-energy x-ray absorptiometry is low.

239 ineral density (BMD) measured by dual-energy x-ray absorptiometry is used to assess bone health in ki

240 e mating for obesity exists when dual-energy X-ray absorptiometry is used to evaluate adiposity.

241 he basis of the relation between dual-energy x-ray absorptiometry-measured fat mass and BMI (in kg/m(

242 l and neonatal anthropometry and dual-energy X-ray absorptiometry measurements of neonatal lean mass

243 rage of 8.2 years (766 follow-up dual energy X-ray absorptiometry measurements).

244 ion, insulin resistance, MRI and dual-energy x-ray absorptiometry measures of body composition and fa

245 iponectin ratio (HMWr), 24-hr ABPM, and dual x-ray absorptiometry measures of fat mass were obtained.

246 d from implant sites were assessed with dual x-ray absorptiometry, microcomputed tomography, and hist

247 ntage of body fat (adiposity) by dual-energy x-ray absorptiometry, moderate-to-vigorous physical acti

248 e examined body composition with dual-energy X-ray absorptiometry, muscle strength with a handgrip dy

249 AEs), and body fat distribution (dual-energy x-ray absorptiometry) of rilpivirine (RPV) and EFV plus

250 mass (n = 28,330) measured using dual energy X-ray absorptiometry or bioelectrical impedance analysis

251 ry outcome was lean body mass by dual-energy x-ray absorptiometry over the 12 week treatment period i

252 dy composition was measured annually by dual X-ray absorptiometry, physical activity by accelerometry

253 Dual-energy x-ray absorptiometry predicts fractures similarly for me

254 ding fasting blood samples and a dual-energy X-ray absorptiometry scan (subset of 650) from which met

255 ted with the use of a total body dual-energy X-ray absorptiometry scan at 20 y of age.

256 Canada, referred for a baseline dual-energy x-ray absorptiometry scan from January 1, 1996, to March

257 ent anthropometric measurements, dual-energy X-ray absorptiometry scan, as well as dietary and activi

258 By dual-energy X-ray absorptiometry scan, body composition was unaltere

259 c-euglycemic clamp, VO2max test, dual-energy X-ray absorptiometry scan, underwater weighing, and musc

260 Whole-body dual-energy X-ray absorptiometry scanning revealed that bone-mass ac

261 Dual-energy X-ray absorptiometry scanning was done at baseline and w

262 ody composition assessment using dual energy x-ray absorptiometry scanning with energy expenditure me

263 udiometry (hearing loss, 22.6%), dual-energy x-ray absorptiometry scans (low bone mineral density [BM

264 sis treatment with 2 consecutive dual-energy x-ray absorptiometry scans (mean interval, 4.5 years).

265 BMD (total and subregions) measured by dual x-ray absorptiometry scans and complete information on c

266 bone measures were derived from dual-energy X-ray absorptiometry scans at a mean age of 9.9 y.

267 studied a subset with whole-body dual-energy X-ray absorptiometry scans at baseline and during follow

268 BMD between the first and second dual-energy x-ray absorptiometry scans categorized as stable, detect

269 n 1993 and 1998 who had received dual-energy x-ray absorptiometry scans for estimation of total body

270 ured by specific software on the dual-energy x-ray absorptiometry scans of lumbar spine in 39 KTR and

271 ginning of the trial, and serial dual-energy x-ray absorptiometry scans of the lumbar spine were perf

272 ients in which serial whole-body dual-energy X-ray absorptiometry scans were performed.

273 Total body fat, measured from dual energy x-ray absorptiometry scans, was the primary outcome.

274 fat (%BF) was measured by using dual-energy X-ray absorptiometry; sleeping metabolic rate (SMR), res

275 Dual energy X-ray absorptiometry studies revealed increased central

276 , the percentage of fat by using dual-energy X-ray absorptiometry, symptoms of depression and anxiety

277 ce fragility fractures at better dual-energy x-ray absorptiometry T-scores than those with postmenopa

278 There are limitations of dual-energy x-ray absorptiometry technology in this population, incl

279 easured the aBMD with the use of dual-energy X-ray absorptiometry, the distal radius and tibia bone m

280 nfants' anthropometrics and used dual-energy X-ray absorptiometry to assess body composition at 1, 4,

281 skeletal muscle phenotypes using dual energy x-ray absorptiometry, ultrasound and isokinetic dynamome

282 ) were estimated with the use of dual-energy X-ray absorptiometry, underwater weighing (UWW), and TBW

283 t and lean body mass measured by dual-energy x-ray absorptiometry was analyzed as z scores.

284 Dual-energy X-ray absorptiometry was performed at baseline and 24-we

285 e change in body fat measured by dual-energy X-ray absorptiometry was smaller (P = 0.001) in the CLA

286 Dual-energy X-ray absorptiometry was used to assess body composition

287 Dual-energy X-ray absorptiometry was used to assess body composition

288 Dual-energy X-ray absorptiometry was used to calculate adiposity.

289 Dual-energy X-ray absorptiometry was used to measure total bone mine

290 BMD, measured using dual-energy x-ray absorptiometry, was assessed at the lumbar spine,

291 Using dual-energy X-ray absorptiometry, we compared lumbar spine, total hi

292 n weight and body composition by dual-energy X-ray absorptiometry were measured.

293 Cycle ergometry and dual-energy X-ray absorptiometry were obtained in 50 TX and 70 contr

294 Laboratory analysis and dual energy X-ray absorptiometry were performed at baseline and ever

295 ary records, accelerometers, and dual-energy X-ray absorptiometry were used to assess diet, activity,

296 y magnetic resonance imaging and dual-energy x ray absorptiometry) were assessed using multivariable

297 ic clamp), and body composition (dual-energy X-ray absorptiometry) were examined.

298 ilable body-composition data (by dual-energy X-ray absorptiometry) were used.

299 t and fat-free mass, measured by dual-energy X-ray absorptiometry, were converted to calorie equivale

300 l body fat was measured by using dual-energy X-ray absorptiometry, whereas abdominal VAT and SAT cros